Description

Viziprox-CV 325 is a broad-spectrum antibiotic combination containing Cefpodoxime 200 mg and Clavulanic Acid 125 mg, formulated to effectively treat a wide range of bacterial infections. Cefpodoxime, a third-generation cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid enhances its effectiveness by protecting it from bacterial resistance mechanisms. This combination is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial conditions. Viziprox-CV 325 provides enhanced antibacterial coverage and supports faster recovery. For safe and effective treatment, it should be taken strictly as advised by your doctor or healthcare professional and for the full prescribed course.